Allmade lands pre-Series A for its quantum dot diagnostics platform
What's the deal? AllmadeDealroom has a profile for this one. Try Dealroom →, a South Korean startup building a non-invasive point-of-care testing (POCT) platform, has raised a pre-Series A round from Kookmin University Technology Holdings and Minetta BrookDealroom has a profile for this one. Try Dealroom →. The amount was not disclosed. It marks the first investment in the round, announced on 10 August 2026.
What's the endgame? Allmade is developing a next-generation in-vitro diagnostics platform based on quantum dot light-emitting signals, in the works since 2025. Quantum dots are ultra-fine semiconductor particles that emit different colours by size; the company is combining them with bio materials for high-sensitivity diagnostics and precision sensing.
What's the money for? Allmade plans to accelerate commercialisation of the quantum dot platform and expand early revenue. Its lead products are rapid test kits for inflammatory bowel disease (Calprotectin) and colorectal cancer (FOB).
Why now? The startup showed its kits at Vietnam's K Med Expo in June 2026 and plans to appear at Singapore's Medical Fair Asia later in 2026 to build an export base. The round follows a seed investment in April 2025 from a Bigbang VenturesDealroom has a profile for this one. Try Dealroom → fund.
Minetta Brook co-chief executives Kim Ji-cheol and Koo Tae-hoon said Allmade is a "deep-tech bio company" combining quantum dot diagnostics with the market potential of non-invasive testing. They added the firm plans to continue support, including a TIPS recommendation for R&D funding.
Chief executive Oh Taek-gyu said the company aims to "wrap up the pre-Series A round without a hitch" and speed up commercialisation to accelerate its move into global markets.
The signal: The deal lands amid a run of Korean materials and components startups drawing investment. AI chip firm Rebellions is supplying server-type NPUs to public CCTV systems, while climate-tech firm CEL LABDealroom has a profile for this one. Try Dealroom → raised from Kryton InternationalDealroom has a profile for this one. Try Dealroom → to build large-scale membrane production — a sign investors are backing domestic deep-tech across sectors.
Read more: Wowtale
Image credit: jurvetson via Openverse
